Menu

CDC to Drastically Cut Efforts to Prevent Global Disease Outbreaks

The agency’s plan to scale back work in 39 foreign countries could hamper its ability to rapidly respond to future epidemics.

Feb 1, 2018
Ashley Yeager

PIXABAY, BHOSSFELDDue to dwindling funding, the Centers for Disease Control and Prevention (CDC) plans to scale back or discontinue efforts to prevent infectious-disease epidemics and other health threats in 39 of 49 foreign countries. This work was supported by a five-year, $582-million supplemental package awarded to the CDC and other government agencies in 2015 to respond to the Ebola epidemic in West Africa. But the funds run out in September 2019.

According to The Washington Post, a coalition of global health organizations sent a letter to US Health and Human Services Secretary Alex Azar on Monday (January 29) asking the administration to reconsider the planned reductions to programs. Cutting funds after outbreaks subside can backfire and make subsequent outbreaks even more expensive to manage, the coalition explained. The Ebola outbreak, for example, cost US taxpayers $5.4 billion in emergency supplemental funding, the article notes. It also added costs as a result of forced containment in US cities, military deployment, and disruption to global business.

An anonymous source tells The Washington Post that the CDC began notifying staffers and officials two weeks ago about the reduction in efforts because of “no new resources.”

In an email to staffers reviewed by The Wall Street Journal, the CDC says that it will continue global health security activities in 10 countries: India, Thailand, Vietnam, Kenya, Uganda, Liberia, Nigeria, Senegal, Jordan, and Guatemala. It will scale back efforts in China, Pakistan, Haiti, Rwanda, and Congo—some of the world’s hot spots for emerging infectious diseases.

An anonymous source tells The Washington Post that if more funding becomes available in the fiscal year starting October 1, the CDC could resume work in China and Congo, as well as Ethiopia, Indonesia, and Sierra Leone.

The president's fiscal 2019 budget, which will be released soon, should reveal whether officials who have urged for more funding for global health security were heard or not.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Enabling Genomics-Guided Precision Medicine

Enabling Genomics-Guided Precision Medicine

Download this eBook from Qiagen to learn more about the promise of precision medicine and how QCITM Interpret can help deliver better care with better knowledge.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!